523 / 815
IMRT in breast cancer: data accumulating
Phase III Randomised Trial
WBI vs IMRT
1145 pts
End-point: late toxicity
Results
– IMRT – less telangiectasia
– No impact on breast shape
Not
standard
Barnett et al.
IJROBP
2012
|
|
523 / 815
IMRT in breast cancer: data accumulating
Phase III Randomised Trial
WBI vs IMRT
1145 pts
End-point: late toxicity
Results
– IMRT – less telangiectasia
– No impact on breast shape
Not
standard
Barnett et al.
IJROBP
2012